[1] 邵祝军,徐英春,徐丽,等.22株脑膜炎奈瑟菌对治疗和预防用抗菌药的体外敏感性[J].中国感染与化疗杂志,2007,7(6):435-437. [2]CLSI .Performance standards for antimicrobial susceptibility testing:sixteenth informational supplement[S]. United States :CLSI,2006. [3]王晓萍,靳玉惠,黄泓艳.合肥市2004 年流行性脑膜炎疫情分析[J].中国计划免疫,2006,12( 1): 50. [4] ABADI F J,CARTER P E,CASH P,et al.Rifampin resistance in Neisseria meningitidis due to alterations in membrane permeability Antimicrob[J]. Agents Chemother,1996,40:646-651. [5]JAMES H J,SHARON A C.Suscept ibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents[J]. J Clin Microbiol,2005,43:3162-3171. [6]HEDBERG S T,FREDLUND H,NICOLAS P,et al.Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt,2000 to 2006:phenotypic and genotypic perspectives[J]. Antimicrob Agents Chemother,2009,53(4):1561-1566. [7]JORGENSEN J H,CRAWFORD S A,FIEBELKORN K R.Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characerization of resistance mechanisms affecting some agents[J]. J Clin Microbiol,2005,43(7):3162-3171. [8]刘美真,杜志明,张莉萍,等.广东省2004年流脑监测结果分析[J].华南预防医学,2005,31(4):18-20. [9]孙健,黄锐敏,鞠长燕.55株脑膜炎奈瑟菌对12种抗生素体外敏感性试验[J].中国热带医学,2008,8(2):286-287. [10]田晓辉,夏昕,王敏,等. 张家界市首例C群流脑死亡病例及其密接人群中分离的脑膜炎奈瑟菌实验室分析和PFGE 分型[J]. 实用预防医学,2012,19(9):1311-1295. [11]李德好,胡绪敬,徐丽,等 脑膜炎奈瑟氏菌对常用抗菌药物敏感性监测[J].疾病监测,1996,11(11):405. [12]权怡,方锦嵩,林玫,等.广西脑膜炎奈瑟菌体外抗菌药物敏感性检测[J].中国卫生检验杂志,2012,22(9):2220-2224. [13]刘美真,管大伟,邓小玲,等.广东省首例W135群流脑的病原学分析[J].华南预防医学,2008,34(3):26-28. [14]QUAGLIARELLO V J,SCHELD W M.Treatment of bacterial menin |